These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15609123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
    Yeo W, Chan PK, Ho WM, Zee B, Lam KC, Lei KI, Chan AT, Mok TS, Lee JJ, Leung TW, Zhong S, Johnson PJ.
    J Clin Oncol; 2004 Mar 01; 22(5):927-34. PubMed ID: 14990649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 01; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.
    Dai MS, Wu PF, Shyu RY, Lu JJ, Chao TY.
    Liver Int; 2004 Dec 01; 24(6):540-6. PubMed ID: 15566502
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
    Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ.
    J Med Virol; 2003 Aug 01; 70(4):553-61. PubMed ID: 12794717
    [Abstract] [Full Text] [Related]

  • 9. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.
    Ann Hematol; 2004 May 01; 83(5):270-5. PubMed ID: 15060745
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.
    Jang JW, Choi JY, Bae SH, Yoon SK, Chang UI, Kim CW, Cho SH, Han JY, Lee YS.
    Hepatology; 2006 Feb 01; 43(2):233-40. PubMed ID: 16440357
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B.
    Cancer Invest; 2006 Feb 01; 24(5):548-52. PubMed ID: 16939967
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ.
    Ann Hematol; 2008 Jun 01; 87(6):481-5. PubMed ID: 18299831
    [Abstract] [Full Text] [Related]

  • 13. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T, Garipidou V, Tziomalos K, Perifanis V, Giouleme O, Vakalopoulou S.
    Am J Hematol; 2005 Nov 01; 80(3):197-203. PubMed ID: 16247746
    [Abstract] [Full Text] [Related]

  • 14. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY, Choi JY, Jang JW, You CR, Bae SH, Yoon SK, Yang JM, Choi SW, Han NI, Kim DG.
    J Med Virol; 2008 Nov 01; 80(11):1891-9. PubMed ID: 18814257
    [Abstract] [Full Text] [Related]

  • 15. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
    Hsu C, Hsiung CA, Su IJ, Hwang WS, Wang MC, Lin SF, Lin TH, Hsiao HH, Young JH, Chang MC, Liao YM, Li CC, Wu HB, Tien HF, Chao TY, Liu TW, Cheng AL, Chen PJ.
    Hepatology; 2008 Mar 01; 47(3):844-53. PubMed ID: 18302293
    [Abstract] [Full Text] [Related]

  • 16. Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
    Yeo W, Hui EP, Chan AT, Ho WM, Lam KC, Chan PK, Mok TS, Lee JJ, Mo FK, Johnson PJ.
    Am J Clin Oncol; 2005 Aug 01; 28(4):379-84. PubMed ID: 16062080
    [Abstract] [Full Text] [Related]

  • 17. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
    Kohrt HE, Ouyang DL, Keeffe EB.
    Clin Liver Dis; 2007 Nov 01; 11(4):965-91, x. PubMed ID: 17981237
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 01; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 19. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
    Sugimoto R, Enjoji M, Kotoh K, Noguchi K, Tsuruta S, Nakamuta M, Nawata H.
    Fukuoka Igaku Zasshi; 2004 Oct 01; 95(10):274-9. PubMed ID: 15678886
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.